160 results have been found
September 28, 2021
Grifols begins commercializing TAVLESSE® in France, Italy and Spain to treat chronic immune thrombocytopenia
August 16, 2021
Grifols advances on its strategic investment from GIC with 90% of consents from its notes holders and lenders
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?